All In Biotech

Drug Trial Radar · NCT05359861

Trial of Atezolizumab and Bevacizumab With CHS-388 or Placebo in Patients With Hepatocellular Carcinoma

A Randomized Phase 2 Trial of Atezolizumab and Bevacizumab in Combination With CHS-388 (Formerly Known as SRF388) or Placebo in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma.

Last checked: Nov 20, 2026Latest source record: Oct 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

30

Actual

Start

Apr 12, 2022

Primary completion

Jun 30, 2025

Study completion Jul 8, 2025

Sponsor

Lead sponsor
Coherus Oncology, Inc.Industry
Sponsor type
Industry
First posted
May 4, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This was a Phase 2 trial composed of an open label Lead-In followed by a planned Randomized Phase designed to evaluate the efficacy and safety of SRF388 in combination with atezolizumab plus bevacizumab compared to placebo (inactive substance) in combination with atezolizumab plus bevacizumab in patients with first-line advanced or metastatic HCC. Only the Lead-In Phase of the study was completed.

Conditions

  • Hepatocellular Carcinoma

Interventions

  • CasdozokitugDrug

    Casdozokitug will be administered by intravenous injection (IV)

  • AtezolizumabDrug

    Atezolizumab will be administered by IV

  • BevacizumabDrug

    Bevacizumab will be administered by IV

  • PlaceboDrug

    Placebo will be administered by IV

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Treatment-emergent Adverse Events (TEAEs)Time frame: Up to approximately 37 months

Locations

37 sites in 4 countries. Site status is shown where the registry gives one.

  • University of Arizona Cancer Center - North Campus

    Tucson, Arizona

  • City of Hope

    Duarte, California

  • University of Southern California - Norris Comprehensive Cancer Center

    Los Angeles, California

  • University of Florida Health Science Center - Gainesville

    Gainesville, Florida

  • University of Miami, Sylvester Comprehensive Cancer Center

    Miami, Florida

  • Louisville VA Medical Center - Robley Rex VA Medical Center

    Louisville, Kentucky

  • Veterans Affairs Ann Arbor Healthcare System

    Ann Arbor, Michigan

  • University of Michigan Health System (UMHS)

    Ann Arbor, Michigan

  • Henry Ford Hospital

    Detroit, Michigan

  • Veterans Affairs New York Harbor Healthcare System - Manhattan VA Medical Center

    New York, New York

  • NYU Langone Medical Center - Laura and Isaac Perlmutter Cancer Center (NYU Cancer Institute (NYUCI))

    New York, New York

  • University of Oklahoma Health Sciences Center - Stephenson Cancer Center

    Oklahoma City, Oklahoma

  • Providence Portland Medical Center

    Portland, Oregon

  • Sarah Cannon Research Institute - Tennessee Oncology

    Chattanooga, Tennessee

  • Sarah Cannon Research Institute - Tennessee Oncology

    Nashville, Tennessee

  • St George Hospital -Kogarah

    Kogarah, Australia

  • The Alfred Hospital

    Melbourne, Australia

  • Royal Melbourne Hospital

    Melbourne, Australia

  • Gold Coast Private Hospital

    Southport, Australia

  • Daegu Catholic University Medical Center (DCUMC)

    Daegu, South Korea

  • Chonnam National University (CNU) - Chonnam National University Hwasun Hospital (CNUHH)

    Gwangju, South Korea

  • Ajou University Hospital

    Gyeonggi-do, South Korea

  • CHA University - Bundang CHA General Hospital (CHA Bundang Medical Center)

    Gyeonggi-do, South Korea

  • Seoul National University Bundang Hospital

    Seongnam, South Korea

  • Severance Hospital

    Seoul, South Korea

  • Gangnam Severance Hospital - Cancer Hospital

    Seoul, South Korea

  • Korea University Medical Center - Korea University Anam Hospital

    Seoul, South Korea

  • University of Ulsan College of Medicine - Asan Medical Center (AMC)

    Seoul, South Korea

  • Seoul National University Hospital (SNUH) - SMG-SNU Boramae Medical Center

    Seoul, South Korea

  • Pusan National University Yangsan Hospital

    Yangsan, South Korea

  • The Catholic University of Korea - St. Vincent's Hospital

    Suwon, Gyeonggi-do, South Korea

  • Buddhist Tzu Chi General Hospital - Hualien Tzu Chi Medical Center

    Hualien City, Taiwan

  • Kaohsiung Medical University - Chung-Ho Memorial Hospital

    Kaohsiung City, Taiwan

  • E-Da Cancer Hospital

    Kaohsiung City, Taiwan

  • Chang Gung Memorial Hospital - Kaohsiung Branch

    Kaohsiung City, Taiwan

  • China Medical University Hospital

    Taichung, Taiwan

  • National Taiwan University Hospital

    Taipei, Taiwan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.